Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 360 Neoplasms 255 Carcinoma, Non-Small-Cell Lung 199 Colorectal Neoplasms 183 Lung Neoplasms 152 Prostatic Neoplasms 151 Carcinoma, Hepatocellular 128 Leukemia, Myeloid, Acute 96 Pancreatic Neoplasms 86 Multiple Myeloma 84 Neoplasm Metastasis 74 Recurrence 71 Uterine Cervical Neoplasms 69 Rectal Neoplasms 68 Stomach Neoplasms 65 Ovarian Neoplasms 65 Triple Negative Breast Neoplasms 60 Squamous Cell Carcinoma of Head and Neck 57 Head and Neck Neoplasms 54 Glioblastoma 54 Brain Neoplasms 54 Precursor Cell Lymphoblastic Leukemia-Lymphoma 51 Small Cell Lung Carcinoma 50 Endometrial Neoplasms 47 Melanoma 44 Esophageal Neoplasms 43 Disease 43 Colonic Neoplasms 42 Hematologic Neoplasms 41 Glioma 40

Interventions

18-O-demethylcervinomycin A2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × ER+HER2- Breast Cancer × 1 year × Clear all

NCT07109284 2025-08-07

NeoSaciA

West China Hospital

Phase 2 Not yet recruiting

ER+HER2- Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡